Select your Country or Region

  • TargetMol | Compound LibraryArgentinaArgentina
  • TargetMol | Compound LibraryAustraliaAustralia
  • TargetMol | Compound LibraryAustriaAustria
  • TargetMol | Compound LibraryBelgiumBelgium
  • TargetMol | Compound LibraryBrazilBrazil
  • TargetMol | Compound LibraryBulgariaBulgaria
  • TargetMol | Compound LibraryCroatiaCroatia
  • TargetMol | Compound LibraryCyprusCyprus
  • TargetMol | Compound LibraryCzechCzech
  • TargetMol | Compound LibraryDenmarkDenmark
  • TargetMol | Compound LibraryEgyptEgypt
  • TargetMol | Compound LibraryEstoniaEstonia
  • TargetMol | Compound LibraryFinlandFinland
  • TargetMol | Compound LibraryFranceFrance
  • TargetMol | Compound LibraryGermanyGermany
  • TargetMol | Compound LibraryGreeceGreece
  • TargetMol | Compound LibraryHong KongHong Kong
  • TargetMol | Compound LibraryHungaryHungary
  • TargetMol | Compound LibraryIcelandIceland
  • TargetMol | Compound LibraryIndiaIndia
  • TargetMol | Compound LibraryIrelandIreland
  • TargetMol | Compound LibraryIsraelIsrael
  • TargetMol | Compound LibraryItalyItaly
  • TargetMol | Compound LibraryJapanJapan
  • TargetMol | Compound LibraryKoreaKorea
  • TargetMol | Compound LibraryLatviaLatvia
  • TargetMol | Compound LibraryLebanonLebanon
  • TargetMol | Compound LibraryMalaysiaMalaysia
  • TargetMol | Compound LibraryMaltaMalta
  • TargetMol | Compound LibraryMoroccoMorocco
  • TargetMol | Compound LibraryNetherlandsNetherlands
  • TargetMol | Compound LibraryNew ZealandNew Zealand
  • TargetMol | Compound LibraryNorwayNorway
  • TargetMol | Compound LibraryPolandPoland
  • TargetMol | Compound LibraryPortugalPortugal
  • TargetMol | Compound LibraryRomaniaRomania
  • TargetMol | Compound LibrarySingaporeSingapore
  • TargetMol | Compound LibrarySlovakiaSlovakia
  • TargetMol | Compound LibrarySloveniaSlovenia
  • TargetMol | Compound LibrarySpainSpain
  • TargetMol | Compound LibrarySwedenSweden
  • TargetMol | Compound LibrarySwitzerlandSwitzerland
  • TargetMol | Compound LibraryTaiwan,ChinaTaiwan,China
  • TargetMol | Compound LibraryThailandThailand
  • TargetMol | Compound LibraryTurkeyTurkey
  • TargetMol | Compound LibraryUnited KingdomUnited Kingdom
  • TargetMol | Compound LibraryUnited StatesUnited States
  • TargetMol | Compound LibraryOther CountriesOther Countries
Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Cimicifuga

  • Cimicifugoside H-1
    TN1494163046-73-9
    Cimicifugoside H1 shows the protective function to cerebral neuron during cerebral ischemia.
    • $80
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
    TargetMol | Citations Cited
  • Cimidahurinine
    TN3653142542-89-0
    Cimidahurinine can attenuate Doxorubicin (DOX)-induced cardiotoxicity in a dose-dependent manner with EC50 values of 45.79 uM; it protects against cardiotoxicity by decreasing reactive oxygen species (ROS) accumulation and downregulating apoptosis-related Bax/Bcl-2 proteins.
    • $169
    Backorder
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Cimiside E
    TN3655154822-57-8
    Cimiside E has anti-inflammatory activity, it selectively inhibits TNF-α-induced expression of VCAM-1 at least by upregulation of PPAR-γ, and signals for ERK1/2, PI3K, and PKC are involved in this effect.Cimiside E may be an effective chemopreventive agen
    • Inquiry Price
    Size
    QTY
    TargetMol | Inhibitor Sale
  • 7,8-Didehydrocimigenol
    TN3219150972-72-8
    7,8-Didehydrocimigenol can be used for the treatment of cardiovascular disorders such as atherosclerosis. It upregulates PPAR-γ in EC inhibits NF-kB activity of TNF-α-activated EC which leads to selective inhibition of VCAM-1 expression.
    • $550
    Backorder
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Cimicidanol 3-O-alpha-L-arabinoside
    T4S1672161207-05-2
    Cimicidanol 3-O-alpha-L-arabinoside is a natural product of Cimicifuga, Ranunculaceae. The catalog number is T4S1672 and the CAS number is 161207-05-2. Cimicidanol 3-O-alpha-L-arabinoside can be used as a reference standard.
    • $190
    Backorder
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Cimiracemoside D
    T5S1677290821-39-5
    Cimiracemoside D is a natural product from Cimicifuga foetida L.
    • $100
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Cimigenol-3-one
    TN149731222-32-9
    Cimigenol-3-one is a natural product from Calophyllum inophyllum.
    • $2,160
    Backorder
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Acetylshengmanol Arabinoside
    T5S1679402513-88-6
    Acetylcimigenol 3-O-alpha-L-arabinopyranoside is an extract derived from Cimicifuga.
    • $39
    In Stock
    Size
    QTY
  • Cimiracemoside C
    TN1499256925-92-5
    Cimiracemoside C (Cimicifugoside M) is an active component of Cimicifuga racemosa. It activates AMPK and has the potential activity against diabetes.
    • $54
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Cimifugin
    T338337921-38-3
    Cimifugin (Cimitin) inhibits NO production induced by lipopolysaccharide in macrophage cell line RAW 264.7 and for 1, 1-diphenyl-2-picrylhydrazyl free-radical scavenging activity in cell-free bioassay system.
    • $70
    In Stock
    Size
    QTY
  • 25-Anhydrocimigenol 3-O-beta-D-xyloside
    TN2825181765-11-7
    25-Anhydrocimigenol 3-O-beta-D-xyloside has notable cytotoxicity against HepG2 and MCF-7 cancer cell lines.
    • $550
    Backorder
    Size
    QTY
  • Norkhellol
    TN46694439-68-3
    Norkhellol is a natural product for research related to life sciences. The catalog number is TN4669 and the CAS number is 4439-68-3.
    • $520
    Backorder
    Size
    QTY
  • Cimicifugoside H2
    TN1495161097-77-4
    Cimicifugoside H2 is a natural product from Cimicifuga foetida.
    • Inquiry Price
    Size
    QTY
  • Cimigenol
    TN14983779-59-7
    Cimigenol is a potential antitumor compound, combination of it with an autophagy inhibitor may be a valuable strategy for the chemoprevention or treatment of colon cancer. It exerted potent cytotoxic activity against SMMC-7721 (7.87μM) and A-549 (12.16 μM
      7-10 days
      Inquiry
    • DL-Isocitric acid trisodium salt
      T50871637-73-6
      DL-Isocitric acid trisodium salt is the protonated form of isocitrate, a substrate in the citric acid cycle. DL-Isocitric acid trisodium salt is useful as a marker for determining the composition of isocitrates in fruit products, including fruit juices.
      • $50
      In Stock
      Size
      QTY
    • Cimicifugic acid B
      TN3652205114-66-5
      Cimicifugic acid B is a natural product for research related to life sciences. The catalog number is TN3652 and the CAS number is 205114-66-5.
      • Inquiry Price
      Size
      QTY
    • Actein
      T719018642-44-9
      Actein has a stimulatory effect on osteoblastic bone formation or has potential activity against osteoporosis, it also can prevent oxidative damage to osteoblasts in osteoporotic patients. Actein's ability to pathways involved in lipid disorders and carci
      • $147
      In Stock
      Size
      QTY
    • Cimigenoside
      T6S167627994-11-2
      Cimigenoside, a constituent of Asclepias, is a γ-secretase inhibitor that inhibits the proliferation or metastasis of human breast cancer cells via the γ-secretase/Notch axis.
      • $52
      In Stock
      Size
      QTY
    • prim-O-Glucosylangelicain
      TN482885889-15-2
      prim-O-Glucosylangelicain is a natural product from Cimicifuga foetida L.
      • $460
      Backorder
      Size
      QTY
    • 26-Deoxycimicifugoside
      TN1229214146-75-5
      26-Deoxycimicifugoside is a natural product from Cimicifuga foetida L.
      • $647
      Backorder
      Size
      QTY
    • Prim-O-glucosylcimifugin
      T380580681-45-4
      Prim-O-glucosylcimifugin (Cimifugin 7-glucoside) can inhibit the proliferation of SMC(smooth muscle cell) stimulated by TNF-alpha, increase the proportion of G0/G1 phase.
      • $55
      In Stock
      Size
      QTY
    • 26-Deoxyactein
      TN1222264624-38-6
      23-epi-26-Deoxyactein (27-Deoxyactein) has anti-inflammatory activity, it inhibits nitric oxide production by reducing iNOS expression without affecting activity of the enzyme. It also has anti-cancer activity, it can inhibit growth of the MCF7 human breast cancer cells and induce cell cycle arrest at G1.
      • $98
      In Stock
      Size
      QTY